On February 6, the FDA made history by approving the first drug made with materials from genetically engineered (GE) goats. Last month the Agency issued guidelines covering how it will regulate products from genetically altered animals, despite controversy about this technology. The bottom line is that this stamp of approval comes with little knowledge of […]
Ralph Moss, PhD, author of the CancerDecision newsletter, has brought attention to a proposed change in Medicare rules regarding payment of anticancer drugs.
In 2001, the Centers for Disease Control and Prevention (CDC) released the National Report on Human Exposure to Environmental Chemicals, which unveiled the first available benchmarks for a few of the thousands of chemicals to which we are all exposed. The report is based on blood/urine samples taken in twelve US locations from about 3,800 […]
In September of 2005, Council for Responsible Nutrition (CRN) senior vice president of scientific and international affairs, John Hathcock, PhD, wrote a letter to the FDA stating that “Pyridoxamine is unequivocally a dietary ingredient because it is one of the three primary natural forms of vitamin B6, and it is one of the two predominant […]
A study published last week in the online journal Environmental Health Perspectives has cast additional doubt on the FDA’s position that BPA (Bisphenol A) is safe. Canadian health authorities have already outlawed BPA, calling it a health and environmental hazard.
Columnist George Will in the January 29 issue of the Washington Post first noted that “The stimulus legislation creates a council for Comparative Effectiveness Research. This is about medicine but not about healing the economy. The CER would identify (this is language from the draft report on the legislation) medical ‘items, procedures, and interventions’ that […]
The FDA has a petition pending before it. It is FDA Docket No. 2006P-0158. The petition was filed on April 7, 2006, by Citizens for Health. The FDA acknowledged the petition the day it was filed. The petition asked that the FDA revoke its approval of sucralose (also known as Splenda).
The transition period is over. Inauguration Day has ushered in the Obama administration. Many voiced their hopes for the new president through Change.gov, and a health freedom proposal garnered many votes of support.
It is time to make your voice known. As the new Obama administration rolls up its collective sleeves, the details of the coming economic stimulus bill have become known. A key issue for everyone is the privacy of your medical records. AAHF has written an excellent position paper on medical privacy.
Vitamin D has been called the “buzz” vitamin of 2008. It’s early 2009 and current medical research demonstrating the benefits of optimal vitamin D supplementation is still coming in. Vitamin D has now been found to help diminish age-related mental decline, and vitamin D deficiency is linked to erythropoietic protoporphyria photosensitivity, a metabolic disorder characterized […]